CORT
Companies
NASDAQ
Corcept Therapeutics Inc.
Health Care
$71.24
+$20.85 (+41.38%)
Price Chart
Overview
About CORT
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.
Market Cap
$3.5B
Volume
231.9M
Avg. Volume
138.9M
P/E Ratio
42.29143
Dividend Yield
0.00%
Employees
330.0
Company Information
Risk & Correlation Analysis
Market Correlation
0.92
Moderate Correlation
Volatility
High (0.52)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
Low Sensitivity
GDP Growth
Medium Sensitivity
Liquidity
Medium Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
Medium Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, CORT shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$3.5B
Volume231.9M
P/E Ratio42.29
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
February 27, 2025Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025